Literature DB >> 8616735

Developing a Canadian prescribing practices network. Network Development Committee of the Canadian Prescribing Practices Network Project.

A M Holbrook1, S M MacLeod, P Fisher, M A Levine.   

Abstract

Expenditure on drug therapy in Canada has been growing at a faster rate than spending on any other aspect of health care. Increasing societal pressure to use scarce resources more efficiently, advances in communication technology and data indicating that there is room for improvement in drug prescribing suggest that the time has come for an organized linkage of the available drug-utilization and health-outcomes data-bases across the country. A national prescribing practices network would assist prescribers, researchers and policymakers to optimize prescribing with respect to both cost effectiveness and health outcomes. The authors outline the main concerns addressed in the 1994 report to the National Pharmaceutical Strategy and present the results of discussions by the Canadian Prescribing Practices Network Project with respect to the potential users and data sources of a national network and the communications technology on which it would rely.

Mesh:

Year:  1996        PMID: 8616735      PMCID: PMC1487700     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Systematic reviews of randomised controlled trials: important for clinical pharmacologists.

Authors:  A Herxheimer
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

2.  Loose connections between peer-reviewed clinical journals and clinical practice.

Authors:  R B Haynes
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

Review 3.  A taxonomy and critical review of tested strategies for the application of clinical practice recommendations: from "official" to "individual" clinical policy.

Authors:  J Lomas; R B Haynes
Journal:  Am J Prev Med       Date:  1988       Impact factor: 5.043

4.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1994-01-05       Impact factor: 56.272

5.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

6.  Pharmaceutical health promotion: a new concept in therapeutics.

Authors:  A Mant
Journal:  Soc Sci Med       Date:  1994-08       Impact factor: 4.634

7.  Centers for education and research in therapeutics.

Authors:  R L Woosley
Journal:  Clin Pharmacol Ther       Date:  1994-03       Impact factor: 6.875

8.  Evaluating drugs after their approval for clinical use.

Authors:  W A Ray; M R Griffin; J Avorn
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

9.  Evidence for the effectiveness of CME. A review of 50 randomized controlled trials.

Authors:  D A Davis; M A Thomson; A D Oxman; R B Haynes
Journal:  JAMA       Date:  1992-09-02       Impact factor: 56.272

10.  Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring.

Authors:  T H Grasela; C A Walawander; D L Kennedy; H M Jolson
Journal:  Am J Hosp Pharm       Date:  1993-09
View more
  3 in total

Review 1.  Pharmaceutical policies in Canada. Issues and challenges.

Authors:  D E Angus; H M Karpetz
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

2.  Physician prescribing practices: What do we know? Where do we go? How do we get there?

Authors:  A O Carter; D Strachan; Y Appiah
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

3.  Drug interactions among commonly used medications. Chart simplifies data from critical literature review.

Authors:  N R Crowther; A M Holbrook; R Kenwright; M Kenwright
Journal:  Can Fam Physician       Date:  1997-11       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.